SMARCA4-containing BAF complex maintains glioma stem cells in a cycling, oligodendrocyte precursor cell (OPC)-like state, and disruption of SMARCA4 promotes the progression of differentiation along the astrocytic lineage [124]. Here, SMARCA4 is linked to central nervous system cancer.